According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is £2.78 Million. In 2023 the company made a revenue of £0.42 Million an increase over the revenue in the year 2022 that were of -£3.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.